Biotech

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Alliqua Biomedical Inc. (NASDAQ:ALQA) reported that Celgene Corp /de/ has picked up 8,025,194 of common stock as of 2017-03-16. The acquisition brings the aggregate amount owned by Celgene Corp /de/ to a total of 8,025,194...

When some of the biggest names in the biotechnology space all turn their attention towards one company at once, and especially when that company is a relatively under the radar stock, it's worth taking notice. This is exactly what's happened with VBI Vaccines, Inc. - Ordinary Shares (NASDAQ:VBIV). A list...

CytRx Corporation (NASDAQ:CYTR) shares were down 15.02% on Thursday to $0.685 and an additional 7.65% in after-hours trading to $0.632. The company has a market cap of $75.70 million at 117.32 million shares outstanding. Share prices have been trading in a 52-week range of $0.36 to $3.46. CytRx Corporation is a...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked up 424,064 of common stock as of 2017-05-01. The acquisition brings the aggregate amount owned by Pell Lewis C to a total of 424,064 representing...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Vbi Vaccines Inc. (NASDAQ:VBIV) reported that Opko Health, Inc. has picked up 6,023,014 of common stock as of 2017-03-31. The acquisition brings the aggregate amount owned by Opko Health, Inc. to a total of 6,023,014...